ARCHIVES

Wyden Hearing On Taxol Agreements Mangles Facts In Attempt To Protect ‘Public Interest’

This article is from The Cancer Letter archive.

Vol. 17 No. 32 | August 9, 1991

Download PDF Visit The Full Archive

Related Articles

Report Urges Enhancement Of Cancer Data Systems.

October 20, 2000

Dana-Farber Picks Rosenthal To Direct New Center For Integrated Therapies.

June 23, 2000

Erbitux Plus Radiation, Chemo, Appears To Provide CRs In A Small Phase II Study

February 23, 2007

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998

Herberman Outlines NSABP restructuring In Plan To NCI

May 6, 1994

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

March 22, 2002